Abstract
BackgroundCardiovascular diseases (CVDs) have been the global health problems that cause a substantial burden for the patients and the society. Assessing the Quality of Life (QOL) of CVD patients is critical in the effectiveness evaluation of CVD treatments as well as in determining potential areas for enhancing health outcomes. Through the adoption of a combination of bibliometric approach and content analysis, publications trend and the common topics regarding interventions to improve QOL of CVD patients were searched and characterized to inform priority setting and policy development.MethodsBibliographic data of publications published from 1990 to 2018 on interventions to improve QOL of CVD patients were retrieved from Web of Science. Network graphs illustrating the terms co-occurrence clusters were created by VOSviewer software. Latent Dirichlet Allocation approach was adopted to classify papers into major research topics.ResultsA total of 6457 papers was analyzed. We found a substantial increase in the number of publications, citations, and the number of download times of papers in the last 5 years. There has been a rise in the number of papers related to intervention to increase quality of life among patients with CVD during 1990–2018. Conventional therapies (surgery and medication), and psychological, behavioral interventions were common research topics. Meanwhile, the number of papers evaluating economic effectiveness has not been as high as that of other topics.ConclusionsThe research areas among the scientific studies emphasized the importance of interdisciplinary and inter-sectoral approaches in both evaluation and intervention. Future research should be a focus on economic evaluation of intervention as well as interventions to reduce mental issues among people with CVD.
Highlights
Cardiovascular diseases (CVDs) have been the global health problems that cause a substantial burden for the patients and the society
In 2017, 31.8% (17.79 million cases) of global deaths were attributed to CVDs, plus nearly 336 million disability-adjusted life-years (DALY) [1]
Ischemic heart disease (IHD) and stroke account for the highest standardized death rate among CVD causes [2]
Summary
Cardiovascular diseases (CVDs) have been the global health problems that cause a substantial burden for the patients and the society. Assessing the Quality of Life (QOL) of CVD patients is critical in the effectiveness evaluation of CVD treatments as well as in determining potential areas for enhancing health outcomes. Cardiovascular diseases (CVDs) have been the global health problem with rising prevalence, incidence, and death rates. Ischemic heart disease (IHD) and stroke account for the highest standardized death rate among CVD causes [2]. Episodes of CVDs have complex, long term impacts on the life of patients, which is far beyond survivorship, since their consequences cause impairments in physical and cognitive functioning, which, in turn, limit the daily activities and social interactions of the survivors [3,4,5,6,7]. Assessing the QOL of CVD patients is critical when evaluating the effectiveness of CVD treatments and determining which aspects should be improved
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
